Epidemiology of myeloproliferative neoplasms in the United States

Jyotsna Mehta, Hongwei Wang, Sheikh Usman Iqbal, Ruben Mesa

Research output: Contribution to journalArticlepeer-review

108 Scopus citations


Myelofibrosis (MF), polycythemia vera (PV) and essential thrombocythemia (ET) are three classic BCR ABL fusion gene-negative chronic myeloproliferative neoplasms (MPNs). Though rare, it is important to understand the burden of illness of these disorders for public health planning, healthcare insurers and pharmaceutical manufacturers. Therefore, we have described the incidence of MF and prevalence of MF, ET and PV in the United States between 2008 and 2010 based on data from two large health plans. The incidence of primary MF was about 1 per 100 000 per year and did not vary over the study years. The prevalence of PV (44-57 per 100 000) and ET (38-57 per 100 000) was much higher than that of MF (4-6 per 100 000) or subgroups containing MF (post-PV MF = 0.3-0.7 per 100 000; post-ET MF = 0.5-1.1 per 100 000). Additional research using other national databases and/or study designs is needed to substantiate these findings.

Original languageEnglish (US)
Pages (from-to)595-600
Number of pages6
JournalLeukemia and Lymphoma
Issue number3
StatePublished - Mar 2014


  • Epidemiology
  • Essential thrombocythemia
  • Myelofibrosis
  • Polycythemia
  • Vera

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research


Dive into the research topics of 'Epidemiology of myeloproliferative neoplasms in the United States'. Together they form a unique fingerprint.

Cite this